Literature DB >> 14713205

Early parity significantly elevates mammary tumor incidence in MMTV-c-myc transgenic mice.

M Hunter Jamerson1, Michael D Johnson, Priscilla A Furth, Robert B Dickson.   

Abstract

Female transgenic mice, in which a murine c-myc gene has been placed under the transcriptional control of the mouse mammary tumor virus long terminal repeat, are prone to developing mammary adenocarcinomas. Owing to the manner in which these mammary tumors develop, it is clear that exogenous expression of the c-myc transgene is necessary to but insufficient for murine mammary tumorigenesis. The genetic background of study mice has been shown to influence the phenotype induced by different transgenes; furthermore, mammary tumor initiation and progression induced by different transgenes has been shown to be susceptible to significant modification with alterations in and mixing of the genetic background of the study mice. We bred MMTV-c-myc transgenic mice onto a mixed genetic background that resulted in a very significant suppression of mammary tumor incidence for parous mice, bred continuously starting at 10 weeks of age. In this paper, we show that mammary tumor incidence is significantly elevated in these mixed background MMTV-c-myc transgenic mice when they are bred continuously, starting at 7 weeks of age. Early breeding of these mice did not influence mammary tumor multiplicity, latency, histopathology, or number of pregnancies at time of tumor development. These results are the first to demonstrate that breeding age influences mammary tumor incidence in MMTV-c-myc transgenic mice. They suggest that mammary gland susceptibility to tumorigenesis, resulting from the expression of c-myc, may vary with glandular development as is seen for chemical carcinogens.

Entities:  

Mesh:

Year:  2003        PMID: 14713205     DOI: 10.1023/b:trag.0000005247.69329.ca

Source DB:  PubMed          Journal:  Transgenic Res        ISSN: 0962-8819            Impact factor:   3.145


  19 in total

Review 1.  DNA methylation and chromatin - unraveling the tangled web.

Authors:  Keith D Robertson
Journal:  Oncogene       Date:  2002-08-12       Impact factor: 9.867

Review 2.  Think globally, act locally: the making of a mouse mammary gland.

Authors:  L Hennighausen; G W Robinson
Journal:  Genes Dev       Date:  1998-02-15       Impact factor: 11.361

3.  MMTV promoter hypomethylation is linked to spontaneous and MNU associated c-neu expression and mammary carcinogenesis in MMTV c-neu transgenic mice.

Authors:  H Zhou; W D Chen; X Qin; K Lee; L Liu; S D Markowitz; S L Gerson
Journal:  Oncogene       Date:  2001-09-20       Impact factor: 9.867

4.  Construction and characterization of molecular clones containing integrated mouse mammary tumor virus sequences.

Authors:  L A Donehower; J Andre; D S Berard; R G Wolford; G L Hager
Journal:  Cold Spring Harb Symp Quant Biol       Date:  1980

Review 5.  Interpretation of phenotype in genetically engineered mice.

Authors:  T Doetschman
Journal:  Lab Anim Sci       Date:  1999-04

Review 6.  Insights into cancer from transgenic mouse models.

Authors:  K F Macleod; T Jacks
Journal:  J Pathol       Date:  1999-01       Impact factor: 7.996

7.  Initiating oncogenic event determines gene-expression patterns of human breast cancer models.

Authors:  Kartiki V Desai; Nianqing Xiao; Weili Wang; Lisa Gangi; John Greene; John I Powell; Robert Dickson; Priscilla Furth; Kent Hunter; Raju Kucherlapati; Richard Simon; Edison T Liu; Jeffrey E Green
Journal:  Proc Natl Acad Sci U S A       Date:  2002-05-14       Impact factor: 11.205

8.  Genetic modulation of neu proto-oncogene-induced mammary tumorigenesis.

Authors:  G J Rowse; S R Ritland; S J Gendler
Journal:  Cancer Res       Date:  1998-06-15       Impact factor: 12.701

Review 9.  Experimentally induced mammary tumors in rats.

Authors:  J Russo; I H Russo
Journal:  Breast Cancer Res Treat       Date:  1996       Impact factor: 4.872

10.  Identification of inbred mouse strains harboring genetic modifiers of mammary tumor age of onset and metastatic progression.

Authors:  T Lifsted; T Le Voyer; M Williams; W Muller; A Klein-Szanto; K H Buetow; K W Hunter
Journal:  Int J Cancer       Date:  1998-08-12       Impact factor: 7.396

View more
  1 in total

1.  ΔNp63α-mediated activation of bone morphogenetic protein signaling governs stem cell activity and plasticity in normal and malignant mammary epithelial cells.

Authors:  Amanda L Balboni; Justine A Hutchinson; Andrew J DeCastro; Pratima Cherukuri; Karen Liby; Michael B Sporn; Gary N Schwartz; Wendy A Wells; Lorenzo F Sempere; Paul B Yu; James DiRenzo
Journal:  Cancer Res       Date:  2012-12-14       Impact factor: 12.701

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.